Publication | Closed Access
A clinical trial of radioimmunotherapy with 67Cu-2IT-BAT-Lym-1 for non-Hodgkin's lymphoma.
81
Citations
20
References
1999
Year
67Cu remains an option for future clinical trials. This study established 67Cu-2IT-BAT-Lym-1 as a safe, effective treatment for patients with NHL.
| Year | Citations | |
|---|---|---|
Page 1
Page 1